| Institution: | 1. Drug Policy Modelling Program, University of New South Wales, 22-32 King Street, Randwick NSW 2031, Australia;2. University of British Columbia, 2329 West Mall, Vancouver BC, V6T 1Z4, Canada;1. Johns Hopkins Bloomberg School of Public Health, Department of International Health, 615 N. Wolfe St, Baltimore, MD, 21205, USA;2. Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, 624 N. Broadway, Baltimore, MD, 21205, USA;3. Behavioral Health System Baltimore, 100 S. Charles Street, Baltimore, MD, 21201, USA;4. Baltimore Police Department, 242 W. 29th Street, Baltimore, MD, 21211, USA;1. School of Social Policy, Sociology and Social Research, University of Kent, Chatham, Maritime, Kent ME4 4AG, United Kingdom;2. The School of Law and the Centre for Criminology, University of Greenwich, Queen Mary Building room 217, Old Royal Naval College, Park Row, London, SE10 9LS, United Kingdom;1. ResAd – Research and Development, Ltd., Sokolovska 79/81, Prague 8, 186 00, Czech Republic;2. Uniting Medically Supervised Injecting Centre, Sydney, Australia;3. Institute of Criminology and Social Prevention, Prague, Czech Republic;4. Drug Policy Modelling Program, Social Policy Research Centre, University of New South Wales, Australia;5. Human Enhancement Drugs Network (HEDN), Australia;6. School of Humanities, Arts, Social Sciences and Education, UNE, Armidale, NSW, Australia |
